Effects of the Non-Steroidal MRA Finerenone with and without Concomitant SGLT2 Inhibitor Use in Heart Failure

医学 危险系数 内科学 置信区间 射血分数 安慰剂 比例危险模型 心力衰竭 随机对照试验 人口 环境卫生 病理 替代医学
作者
Muthiah Vaduganathan,Brian Claggett,Ian J. Kulac,Zi Michael Miao,Akshay S. Desai,Pardeep S. Jhund,Alasdair Henderson,Meike Brinker,James Lay‐Flurrie,Prabhakar Viswanathan,Markus F. Scheerer,Andrea Lage,Carolyn S.P. Lam,Michele Senni,Sanjiv J. Shah,Adriaan A. Voors,Faı̈ez Zannad,Bertram Pitt,John J.V. McMurray,Scott D. Solomon
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:151 (2): 149-158 被引量:9
标识
DOI:10.1161/circulationaha.124.072055
摘要

BACKGROUND: Patients with heart failure (HF) with mildly reduced or preserved ejection fraction face heightened long-term risks of morbidity and mortality. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and the nonsteroidal mineralocorticoid receptor antagonist finerenone have both been shown to reduce the risk of cardiovascular events in this population, but the effects of their combined use are not known. METHODS: FINEARTS-HF (Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure) was a randomized, double-blind, placebo-controlled trial of finerenone in patients with HF and left ventricular ejection fraction ≥40%. Baseline SGLT2i use was a prespecified subgroup. The primary outcome was a composite of total (first and recurrent) worsening HF events and cardiovascular death. We first assessed for evidence of treatment heterogeneity on the basis of baseline SGLT2i use. We further examined SGLT2i uptake during the trial and evaluated the treatment effects of finerenone accounting for baseline and during-trial use of SGLT2i in time-varying analyses. RESULTS: Among 6001 participants, 817 (13.6%) were treated with an SGLT2i at baseline. During 2.6 years median follow-up, treatment with finerenone similarly reduced the risk of the primary outcome in participants treated with an SGLT2i (rate ratio, 0.83 [95% CI, 0.60–1.16]) and without an SGLT2i at baseline (rate ratio, 0.85 [95% CI, 0.74–0.98]; P interaction =0.76). In follow-up, 980 participants initiated SGLT2i, which was less frequent in the finerenone arm compared with placebo (17.7% versus 20.1%; hazard ratio, 0.86 [95% CI, 0.76–0.97]). Time-updated analyses accounting for baseline and subsequent use of SGLT2i did not meaningfully alter the treatment effects of finerenone on the primary end point. CONCLUSIONS: The treatment benefits of the nonsteroidal mineralocorticoid receptor antagonist finerenone were observed irrespective of concomitant use of an SGLT2i. These data suggest that the combined use of SGLT2i and a nonsteroidal mineralocorticoid receptor antagonist may provide additive protection against cardiovascular events in patients with HF with mildly reduced or preserved ejection fraction. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04435626.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
HH发布了新的文献求助30
2秒前
大橙子发布了新的文献求助10
3秒前
4秒前
月月完成签到,获得积分10
4秒前
4秒前
哆啦A梦完成签到,获得积分10
5秒前
了尘完成签到,获得积分10
6秒前
wangnn发布了新的文献求助10
7秒前
量子星尘发布了新的文献求助10
7秒前
体贴的叛逆者完成签到,获得积分10
8秒前
幸福的鑫鹏完成签到,获得积分10
8秒前
孤海未蓝完成签到,获得积分10
9秒前
彭于晏应助飒飒采纳,获得10
10秒前
狠毒的小龙虾完成签到,获得积分10
11秒前
小趴菜完成签到,获得积分10
15秒前
lcls完成签到,获得积分10
16秒前
16秒前
17秒前
尊敬太阳发布了新的文献求助10
19秒前
风中夜天完成签到 ,获得积分10
19秒前
优雅友蕊完成签到,获得积分10
20秒前
gaga完成签到,获得积分10
21秒前
西北孤傲的狼完成签到,获得积分10
22秒前
多边形完成签到 ,获得积分10
24秒前
李cc完成签到,获得积分10
26秒前
26秒前
快帮我找找完成签到,获得积分10
26秒前
xiezhuochun完成签到 ,获得积分10
27秒前
30秒前
aixiaoming0503完成签到,获得积分10
31秒前
forge完成签到,获得积分10
31秒前
32秒前
Distance完成签到,获得积分10
35秒前
蒋念寒发布了新的文献求助10
36秒前
雪雨夜心完成签到,获得积分10
40秒前
又是一年完成签到,获得积分10
41秒前
Distance发布了新的文献求助10
42秒前
李子完成签到 ,获得积分10
43秒前
43秒前
耍酷的指甲油完成签到,获得积分20
44秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038184
求助须知:如何正确求助?哪些是违规求助? 3575908
关于积分的说明 11373872
捐赠科研通 3305715
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022